Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Medtronic plc

Start price
Target price
Perf. (%)
€91.39
27.07.22
€100.00
27.07.23
-11.48%
28.07.23

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€44.85
27.07.22
€60.00
27.07.23
5.35%
27.07.23

Future proof or reliable business model
Could be worthwhile Investment >10% per year
Innovative
High dividend yield expected
buy
US Physical Therapy Inc.

Start price
Target price
Perf. (%)
€122.00
26.07.22
-
26.07.23
-9.84%
26.07.23

buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€146.15
15.07.22
€175.00
15.07.23
21.16%
16.07.23

Teladoc Health Inc

Start price
Target price
Perf. (%)
€21.48
24.06.23
€19.00
24.06.24
6.52%
14.07.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Becton, Dickinson & Co.

Start price
Target price
Perf. (%)
€235.25
13.07.22
€239.00
13.07.23
-1.59%
13.07.23

buy
Medtronic plc

Start price
Target price
Perf. (%)
€88.30
13.07.22
€83.00
13.07.23
-11.66%
13.07.23

buy
MicroVision Inc

Start price
Target price
Perf. (%)
€6.25
10.06.23
€7.00
10.06.24
-38.41%
10.07.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Humana Inc.

Start price
Target price
Perf. (%)
€469.25
07.07.22
-
07.07.23
-14.35%
07.07.23

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€26.10
18.04.23
€29.00
18.04.24
-17.70%
24.06.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Sartorius AG VZO

Start price
Target price
Perf. (%)
€418.20
22.07.22
€550.00
22.07.23
-23.00%
30.05.23

Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.26
31.08.22
-
31.08.23
-90.95%
29.05.23

Could be very worthwhile Investment >20% year
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€0.88
17.05.23
-
17.05.24
-25.40%
27.05.23

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.69
31.08.22
-
31.08.23
-93.25%
18.05.23

Could be very worthwhile Investment >20% year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€41.80
12.05.22
-
12.05.23
-6.22%
13.05.23

buy
Glaukos Corp

Start price
Target price
Perf. (%)
€58.00
07.09.22
€63.00
07.09.23
-8.62%
08.05.23

Could be worthwhile Investment >10% per year
buy
Sartorius AG ST

Start price
Target price
Perf. (%)
€554.00
30.11.21
€600.00
31.12.23
-47.29%
08.05.23

Could be worthwhile Investment >10% per year
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€75.50
27.11.21
€100.00
31.12.23
-5.30%
08.05.23

Could be worthwhile Investment >10% per year
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€7.20
08.10.21
€12.00
31.12.23
-94.39%
08.05.23

Could be very worthwhile Investment >20% year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.15
09.09.21
€10.00
31.12.23
-75.78%
08.05.23

Could be very worthwhile Investment >20% year
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€476.00
07.09.21
€550.00
31.12.23
4.08%
08.05.23

Could be very worthwhile Investment >20% year
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€551.50
07.09.22
€700.00
31.12.25
-10.44%
05.05.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year